These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22258053)

  • 1. aPTT prolongation and skin eruption possibly associated with lamotrigine monotherapy in a paediatric patient.
    Yeom JS; Park JS; Seo JH; Park ES; Lim JY; Park CH; Woo HO; Youn HS
    Epileptic Disord; 2011 Dec; 13(4):452-5. PubMed ID: 22258053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible aphasic disorder induced by lamotrigine in atypical benign childhood epilepsy.
    Battaglia D; Iuvone L; Stefanini MC; Acquafondata C; Lettori D; Chiricozzi F; Pane M; Mittica A; Guzzetta F
    Epileptic Disord; 2001 Dec; 3(4):217-22. PubMed ID: 11844717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine triggers the contact phase of coagulation.
    Stief TW
    Epileptic Disord; 2012 Jun; 14(2):195-6; author reply 196. PubMed ID: 22588839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucopenia and thrombocytopenia possibly associated with lamotrigine use in a patient.
    Ural AU; Avcu F; Gokcil Z; Nevruz O; Cetin T
    Epileptic Disord; 2005 Mar; 7(1):33-5. PubMed ID: 15741138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant induced by the combination of valproate and lamotrigine.
    Echaniz-Laguna A; Thiriaux A; Ruolt-Olivesi I; Marescaux C; Hirsch E
    Epilepsia; 1999 Nov; 40(11):1661-3. PubMed ID: 10565597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine and absence seizures: new indication. Try valproic acid first.
    Prescrire Int; 2009 Dec; 18(104):249. PubMed ID: 20025089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children].
    Huang TS; Zhu JL; Li B; Hu Y; Chen L; Liao JX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):653-5. PubMed ID: 19695193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rosea-like eruption associated with lamotrigine.
    Papadavid E; Panayiotides I; Makris M; Giatrakou S; Dalamaga M; Stavrianeas N; Rigopoulos D
    J Am Acad Dermatol; 2013 Jun; 68(6):e180-1. PubMed ID: 23680210
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine.
    Aouam K; Ben Romdhane F; Loussaief C; Salem R; Toumi A; Belhadjali H; Chaabane A; Boughattas NA; Chakroun M
    J Clin Pharmacol; 2009 Dec; 49(12):1488-91. PubMed ID: 19723672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine-induced hypersensitivity syndrome in a Han Chinese patient with the HLA-B 5801 genotype.
    Chow JC; Huang CW; Fang CW; Wu YJ; Tsai JJ
    Neurol Sci; 2013 Jan; 34(1):117-9. PubMed ID: 22258364
    [No Abstract]   [Full Text] [Related]  

  • 14. Myoclonic status epilepticus following high-dosage lamotrigine therapy.
    Guerrini R; Belmonte A; Parmeggiani L; Perucca E
    Brain Dev; 1999 Sep; 21(6):420-4. PubMed ID: 10487478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized purpura associated with lamotrigine.
    Amlie-Lefond CM; Felgenhauer JL; Leong AD
    Pediatr Neurol; 2006 Sep; 35(3):227-8. PubMed ID: 16939867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lamotrigine (LTG) monotherapy.
    Panayiotopoulos CP
    Epilepsia; 2000 Mar; 41(3):357-9. PubMed ID: 10714412
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of acneiform eruption associated with lamotrigine.
    Nielsen JN; Licht RW; Fogh K
    J Clin Psychiatry; 2004 Dec; 65(12):1720-2. PubMed ID: 15641879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.